The Phenylephrine Paradox: What a U.S. FDA Decision Could Mean for Europe
In a move that could reverberate across the Atlantic, a U.S. FDA advisory panel has unanimously declared that oral phenylephrine, a common ingredient in over-the-counter (OTC) cold medications, is ineffective for relieving nasal congestion. This decision could have implications for European consumers and regulators, as phenylephrine is also a staple in many European cold remedies. […]
The Phenylephrine Paradox: What a U.S. FDA Decision Could Mean for Europe Read More »